what is a known effect of glp-1 Exploring the Side Effects Receptor Agonist: To Ensure Its Optimal Positioning What Is GLP-1 and Why

Study Links Wegovy to Possible Increased Risk of Blood Clots According to a 2021 study titled Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials, semaglutide drugs may increase a persons risk of developing a type of blood clot, called a deep vein thrombosis (DVT), by 266%

If retatrutide gains approval with a liver disease indication, it could become a blockbuster on that basis alone

Hernandez AF, Green JB, Janmohamed S et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): a double-blind, randomised placebo-controlled trial

Widely popular GLP-1 drugs have increasingly been shown to provide a range of health benefits, such as reducing the risk of heart and kidney problems

The blood sugar crash that can result from injecting insulin when you do not have diabetes is dangerous and potentially fatal